Early Detection & Intervention of Cerebral Palsy in Ireland

NCT05907837 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2023-10-02

No results posted yet for this study

Summary

Cerebral palsy (CP) is the most common lifelong physical disability. It is defined as a non-progressive disorder of movement originating from neural lesions in the perinatal period, and is associated with a wide range of common comorbidities in many individuals. These include problems speaking, hearing, seeing, thinking, feeding and controlling their bladder. People with CP often have additional challenges such as behavioural and emotional issues, pain, and poor sleep. Many of these challenges respond well to intervention in early childhood, as brain plasticity is at its greatest in the first 2 years of life. However, in most clinical settings, the age for diagnosis of CP is between 24 to 29 months, after this window of neurodevelopmental opportunity.

This project will aim to improve the Early Detection of Cerebral Palsy in Ireland. This will be achieved by implementing an evidence-based approach to follow-up of High risk infants.

Conditions

  • Cerebral Palsy
  • Neurodevelopmental Disorders

Sponsors & Collaborators

  • National Maternity Hospital, Ireland

    collaborator OTHER
  • University Maternity Hospital Limerick

    collaborator UNKNOWN
  • Cork University Maternity Hospital

    collaborator OTHER
  • Coombe Women and Infants University Hospital

    collaborator OTHER
  • The Rotunda Hospital

    collaborator OTHER
  • Cerebral Palsy Foundation

    collaborator UNKNOWN
  • University College Cork

    lead OTHER

Principal Investigators

  • Brian H Walsh · University College Cork

  • Breda Hayes · The Rotunda Hospital

  • Deirdre Sweetman · National Maternity Hospital

  • Roy Philips · Limerick University Maternity Hospital

  • John Kelleher · Coombe Women and Infants University Hospital

Eligibility

Max Age
40 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2027-06-30
Completion
2028-06-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05907837 on ClinicalTrials.gov